Which has the lower trailing P/E, BMY or MRK?

BMY has the lower trailing P/E: BMY trades at 14.02 and MRK at 115.15. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BMY or MRK?

Over the past five years, MRK grew revenue faster — BMY at a 2.08% CAGR versus MRK at 7.87%.

Does BMY or MRK pay a bigger dividend?

BMY yields 3.94% and MRK yields 2.32% based on trailing dividends and the latest price.

Is BMY or MRK more profitable?

BMY runs the higher net margin — BMY at 18.87% versus MRK at 4.78%.

How have BMY and MRK total returns compared?

Over the past 10 years, BMY delivered 5.01% and MRK delivered 12.68% annualized total return. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs Merck & Co., Inc. (MRK)

A side-by-side comparison of Bristol-Myers Squibb Company and Merck & Co., Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

BMY

Bristol-Myers Squibb Company

$130.00B

$63.64HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

MRK

Merck & Co., Inc.

$355.49B

$143.94HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — BMY vs MRK

growth of $100 · dividends reinvested · last 10y

BMY +60.4% (+4.8%/yr)MRK +228.7% (+12.6%/yr)MRK compounded faster over this window

BMY MRK

BMY vs MRK: by the numbers

•MRK is the larger company ($355.49B vs $130.00B market cap).
•BMY trades at the lower trailing earnings multiple (14.02 vs 115.15 P/E), one valuation lens rather than an overall verdict.
•BMY converts more revenue to profit (18.87% vs 4.78% net margin).
•MRK grew revenue faster over the past five years (7.87% vs 2.08% CAGR).
•BMY pays the higher dividend yield (3.94% vs 2.32%).

Metrics side by side

Valuation

Metric	BMY	MRK
P/E ratio	14.02	115.15
Forward P/E	9.18	52.41
P/S ratio	2.64	5.35
P/B ratio	5.82	8.48
EV / EBITDA	9.71	22.76
FCF yield	8.80%	4.52%

Profitability

Metric	BMY	MRK
Gross margin	70.16%	75.38%
Operating margin	28.27%	36.17%
Net margin	18.87%	4.78%
ROE	41.59%	7.57%
ROIC	15.47%	5.80%

Dividends

Metric	BMY	MRK
Dividend yield	3.94%	2.32%
Payout ratio	55.29%	268.80%

Growth (annualized)

Metric	BMY	MRK
Revenue CAGR (5Y)	2.08%	7.87%
EPS CAGR (5Y)	9.38%	21.21%
FCF CAGR (5Y)	-0.95%	23.61%
Total return CAGR (5Y)	4.39%	18.15%

Frequently asked

Which has the lower trailing P/E, BMY or MRK?: BMY has the lower trailing P/E: BMY trades at 14.02 and MRK at 115.15. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BMY or MRK?: Over the past five years, MRK grew revenue faster — BMY at a 2.08% CAGR versus MRK at 7.87%.
Does BMY or MRK pay a bigger dividend?: BMY yields 3.94% and MRK yields 2.32% based on trailing dividends and the latest price.
Is BMY or MRK more profitable?: BMY runs the higher net margin — BMY at 18.87% versus MRK at 4.78%.
How have BMY and MRK total returns compared?: Over the past 10 years, BMY delivered 5.01% and MRK delivered 12.68% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full MRK analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio Merck P/E ratio Bristol-Myers Squibb dividend yield Merck dividend yield Bristol-Myers Squibb ROE Merck ROE Bristol-Myers Squibb operating margin Merck operating margin Bristol-Myers Squibb revenue growth Merck revenue growth Bristol-Myers Squibb free cash flow Merck free cash flow

Bristol-Myers Squibb & Merck appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.